Related Experiment Video
Updated: Jul 29, 2026

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
Published on: September 12, 2011
Regional brain chemical alterations in young children with autism spectrum disorder
S D Friedman1, D W Shaw, A A Artru
1Department of Radiology, University of Washington School of Medicine, Seattle 98105-6099, USA.
Insights
Brain chemistry differences in young children with autism spectrum disorder (ASD) were found, including lower N-acetylaspartate (NAA) and creatine (Cre) levels. These findings do not support the theory of increased neuronal packing density in ASD.
Area of Science:
- Neuroscience
- Biochemistry
- Developmental Pediatrics
Background:
- Autism spectrum disorder (ASD) is a complex neurodevelopmental condition.
- The hypothesis of increased neuronal packing density in ASD has been proposed.
- Understanding brain chemistry in early childhood is crucial for ASD research.
Purpose of the Study:
- To investigate regional brain chemistry in young children with ASD.
- To assess concentrations and relaxation times of key brain metabolites.
- To evaluate the neuronal packing density hypothesis in ASD.
Main Methods:
- Utilized dual-echo proton echoplanar spectroscopic imaging in 3- to 4-year-old children.
- Measured brain chemical concentrations (N-acetylaspartate, creatine, myo-inositol, choline) and relaxation times (T(2r)).
- Compared brain chemistry between children with ASD, typical development (TD), and delayed development (DD), correcting for partial volume effects.
Main Results:
- Children with ASD showed reduced concentrations of N-acetylaspartate (NAA), creatine (Cre), and myo-inositol compared to TD controls.
- ASD subjects exhibited prolonged NAA T(2r) compared to TD and DD groups.
- ASD subjects also showed prolonged T(2r) for choline and Cre compared to the DD group, with subtle regional chemical alterations observed.
Conclusions:
- Brain chemical abnormalities are evident in young children with ASD.
- The observed chemical alterations do not support the hypothesis of diffuse increased neuronal packing density in ASD.
- These findings highlight specific neurochemical differences in early-stage ASD.
Objective:
The authors evaluated regional brain chemistry for evidence of increased neuronal packing density in autism.
Methods:
Forty-five 3- to 4-year-old children with autism spectrum disorder (ASD), 13 children with typical development (TD), and 15 children with delayed development (DD) were studied using dual-echo proton echoplanar spectroscopic imaging (32 x 32 matrix-1 cm(3) voxels) to measure brain chemical concentrations and relaxation times. Chemical quantification was corrected for tissue partial volume and relative measures of chemical relaxation (T(2r)) were calculated from the paired echoes. Measures from averaged and individual regions were compared using analysis of variance corrected for multiple comparisons.
Results:
ASD subjects demonstrated reduced N-acetylaspartate (NAA) (-10%), creatine (Cre) (-8%), and myo-inositol (-13%) concentrations compared to TD controls and prolonged NAA T(2r) relative to TD (7%) and DD (9%) groups. Compared to DD subjects, children with ASD also demonstrated prolonged T(2r) for choline (10%) and Cre (9%). Regional analyses demonstrated subtle patterns of chemical alterations in ASD compared to the TD and DD groups.
Conclusions:
Brain chemical abnormalities are present in ASD at 3 to 4 years of age. However, the direction and widespread distribution of these abnormalities do not support hypothesis of diffuse increased neuronal packing density in ASD.
Related Concept Videos
Neurotransmitters
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Gut-Brain Axis

